Glint Pharmaceuticals Begins Clinical Trials to Treat Corneal Abrasions and Infections
UF startup Glint Pharmaceuticals, an ophthalmic pharmaceutical company that delivers medicated contact lenses to treat eye diseases, announces the start of a phase I safety study to treat corneal infections and superficial injuries.
Glint Pharmaceuticals Announces Formation of Clinical Advisory Board
UF startup Glint Pharmaceuticals, an ophthalmic pharmaceutical company that delivers medicated contact lenses to treat eye diseases, announces the formation of a clinical advisory board composed of notable and experienced clinicians in ophthalmology and optometry.
Glint Pharmaceuticals to Begin Clinical Testing on Contact Lens to Prevent COVID-19 Virus Infection
UF startup Glint Pharmaceuticals, an ophthalmic pharmaceutical company that delivers medicated contact lenses to treat eye diseases, has developed a patented technology... Read More
